Isolated Bilateral Triceps Weakness in Myasthenia Gravis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/37848221/
It is important to recognize this type of myasthenia gravis to facilitate diagnosis and appropriate treatment and to avoid unnecessary investigations and treatments.
A rare case of generalized myasthenia gravis presenting with isolated bilateral triceps weakness is described, emphasizing the importance of recognizing atypical patterns for timely diagnosis and management.
The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40422242/
Myasthenia gravis is an antibody-mediated autoimmune condition characterized by defects in cholinergic transmission at the neuromuscular junction. In AchR antibody-positive patients, complement activation plays a prominent role in the disease...
Complement activation is central to AchR-positive MG pathology. This review highlights therapeutic advances, including C5 inhibitors and emerging targets, shaping novel strategies for treating generalized myasthenia gravis effectively.
Inspiratory muscle training and aerobic exercise for respiratory muscle strength in myasthenia gravis post-hospitalization- a randomized controlled trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40426137/
gov/ ) on October 12, 2024 (retrospectively registered).
Six-week inspiratory muscle training combined with aerobic exercise significantly improved respiratory strength, reduced dyspnea, and enhanced functional capacity in post-hospitalized myasthenia gravis patients compared to standard care alone.
Gender disparities in cognitive impairment across neurological autoimmune disorders: a systematic review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40337166/
CI remains a critical, underexplored aspect of NADs, with gender disparities receiving even less attention. Our review highlights a research imbalance and a lack of specific investigations, leading to overgeneralized...
This systematic review explores gender disparities in cognitive impairment across neurological autoimmune disorders, including myasthenia gravis, revealing limited research and highlighting the need for gender-informed diagnostic and therapeutic approaches.
This network meta-analysis compares novel biologics for myasthenia gravis, showing some efficacy for belimumab, batoclimab, and eculizumab, with no major differences in adverse effects versus placebo.